Oscar Health, Inc. (OSCR) is facing a class action lawsuit (Oscar Health Class Action Lawsuit) alleging that the Company made materially false and/or misleading statements and/or failed to disclose that: (1) Oscar was experiencing growing COVID-19 testing and treatment costs; (2) Oscar was experiencing growing net COVID costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant SEP membership growth; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you incurred a loss on OSCR Class A common stock purchased pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s March 2021 initial public offering, this lawsuit is on your behalf. The lawsuit was filed in the United States District Court for the Southern District of New York, and our firm is reaching out to investors to discuss their legal rights.
If you wish to act as a representative of the shareholders harmed by this misconduct, you may ask the court to appoint you as lead plaintiff. A lead plaintiff directs the litigation and participates in important decisions, including whether to accept a settlement for the class in the action.
You only have until July 11, 2022 to apply to be lead plaintiff. The court will then evaluate the applicants and choose a lead plaintiff. You are not required to act as a lead plaintiff in order to participate in any recovery.
Oscar Health, Inc. Class Action Lawsuit
Oscar Health, Inc. Lawsuit
OSCR Class Action Lawsuit
Oscar Health, Inc. (OSCR) Class Action Lawsuit
Oscar Health Class Action Lawsuit,
Oscar Health Class Action,
Oscar Health Lawsuit,
OSCR Class Action Lawsuit,
OSCR Class Action,